Trial Profile
Thrombectomy Under Reopro Versus Alteplase and Neurologic Deficit Outcome Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Abciximab (Primary) ; Alteplase
- Indications Stroke
- Focus Adverse reactions
- Acronyms TURANDOT
- 24 Apr 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Jan 2014 New trial record